Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FRY | Valuation of FRY shares | 28/10/16 | 17 | 12K | |||
|
|||||||
FRY | Ann: Appendix 3X x 4 | 10/12/15 | 0 | 846 | |||
|
|||||||
FRY | Ann: Appendix 3Z x 3 | 10/12/15 | 0 | 815 | |||
|
|||||||
FRY | Ann: Appendix 3B | 10/12/15 | 0 | 864 | |||
|
|||||||
FRY | Ann: Change of Company Name & ASX Code | 10/12/15 | 0 | 1.2K | |||
|
|||||||
FRY | Ann: Prospectus | 08/12/15 | 12 | 7.4K | |||
|
|||||||
FRY | Ann: Satisfaction & Waiver of All Bid Conditions to Acquire 4D-S | 08/12/15 | 0 | 761 | |||
|
|||||||
FRY | Ann: Public Offer Closes & Update on Status of Bid Conditions | 23/11/15 | 0 | 707 | |||
|
See All Discussions